The market growth is attributed to the prevalence of respiratory disorders and the clinical benefits of capnography equipment over pulse oximetry
The capnography equipment market comprises major competitive players adopting strategies such as product launches, geographic expansion, and technological advancements. A few recent developments in the market are listed below:
The active participation of market players in product innovation and development, and an increase in approvals of products are fueling the growth of the capnography equipment market.
In 2010, the International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science and the American Heart Association (AHA) restructured their guidelines for Adult and Pediatric Advanced Life Support to include recommendations for capnography used during critical events. The new guidelines indorsed the routine use of quantitative waveform capnography for both intubation and during CPR. In the US, the process of proving the medical safety of a device takes ~3–7 years of a manufacturer. Per the law in the country, even if there is a slight change in the size of a previously approved device, the modified product needs to go through the entire process of approval before commercialization. Nevertheless, the FDA approval process for simple capnography equipment is easier than that of complex capnography equipment. The complex capnography equipment needs to comply with various FDA requirements, which act as a hurdle for the approval of capnography equipment on a large scale. The FDA usually evaluates all medical devices for safety and effectiveness, and conducts appropriate assessments to determine the risk-to-benefit ratio. However, in some cases, the body may require manufacturers to provide additional data, depending on the complexity of the device. The current FDA regulations consider capnography equipment in the category of traditionally manufactured medical products for their approval. Thus, variations and lack of standardization in regulations are hampering the growth of the capnography equipment market.
Asia Pacific is expected to register the highest CAGR in the capnography equipment market during the forecast period. High demand for CO2 measurement instruments, increasing prevalence of respiratory diseases, and rising investments in R&D by major market players are among the factors augmenting the growth of the Asia Pacific capnography equipment market. According to the research data published in the Journal of Thoracic Diseases in China, COPD is progressively becoming a cause of public health concern, and it ranks first among the causes of disability. In 2018, the overall prevalence rate of COPD in China was 8.2%, and the mortality rate because of the disease was ~1.6%. COPD is stated to be the fourth leading cause of death in rural areas, with a prevalence rate of 4.4–16.7%. Thus, the growing prevalence of COPD is fueling the growth of capnography market in China. According to Statista, Chinese hospitals led more than 66 million inpatient surgical operations in 2020. The number varied considerably among regions. Health institutions in the southern province of Guangdong conducted more than 8 million operations in the year, while the western province of Qinghai led less than 200,000. The upsurge in the number of surgeries carried out in China is contributing to the growth of the capnography equipment market in APAC.
In India, the market for capnography equipment is rising owing to the growing prevalence of respiratory diseases. For instance, in 2018, according to an article published by DownToEarth, at least 1 in 10 asthma patients present globally lives in India, and the country records ~1.5–2 crore asthma patients. The Indian Study on Epidemiology of Asthma, Respiratory Symptoms and Chronic Bronchitis in Adults (INSEARCH) estimated the national burden of asthma at 17.23 million with an overall prevalence of 2.05%. The recent Global Burden of Disease estimated the total burden of asthma in India as 34.3 million, accounting for 13.09% of the global burden. It also attributed 13.2 thousand deaths in India were due to asthma. Overall, India has three times higher mortality and more than two times higher DALYs compared to the global proportion of asthma burden. The prevalence of asthma due to changing environmental conditions is fueling the growth of the capnography equipment market in India.
Thus, the growing elderly population, prevalence of respiratory diseases, and increase in the number of surgeries are expected to boost the capnography equipment market during the forecast period.
Based on technology, the capnography equipment market is segmented into mainstream capnography, sidestream capnography, and microstream capnography. In 2021, the mainstream capnography segment held the largest share of the market. In mainstream capnography, CO2 sensor is located between endotracheal tube and breathing circuit. It is characterized as invasive and the measurement of ETCO2 is done at the airway or sample site. The growth of the market for mainstream capnography is mainly ascribed to the ease of use, accuracy of monitoring breathing in intubated patients, and shorter response time. In April 2021, Masimo announced the FDA clearance of Radius PCG for the Root Patient Monitoring and Connectivity Platform. The product does not require any routine calibration. It provides accurate ETCO2, respiration rate measurements, and continuous EtCO2 waveforms displayed within 15 seconds.
The sidestream capnography segment is expected to register the highest CAGR in the capnography equipment market during the forecast period. In side-stream capnography, the CO2 is present away from the airway. The sensor is in the main unit and CO2 is collected through a sampling tube connected to a T-piece adapter located in the endotracheal tube and breathing circuit. The side-stream capnography is more comfortable for the patients due to its thin tubing and lighter than main-stream capnography. Further, sidestream technology provides adequate quantitative information about uneven alveolar emptying and ventilation–perfusion mismatch. Masimo offers sidestream capnography solutions with gas monitoring capabilities. It is suitable for gas monitoring across care areas such as pre-hospital, in-hospital to transport, long-term care, and home care.
Companies operating in the capnography equipment market adopt the product innovation strategy to meet the evolving customer demands worldwide, which also allows them to maintain their brand name in the market.
The regional trends and factors influencing the Capnography Equipment Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Capnography Equipment Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 447.59 Million |
| Market Size by 2028 | US$ 716.38 Million |
| Global CAGR (2021 - 2028) | 7.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Capnography Equipment Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Capnography Equipment Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The capnography equipment market is analyzed on the basis of product type, technology, application, end user, and geography. Based on product type, the market is segmented into capnography accessories & disposables and capnometers. Based on technology, the market is segmented into mainstream capnography, sidestream capnography, and microstream capnography. Based on application, the capnography equipment market is segmented into cardiac care, trauma and emergency care, procedural sedation, respiratory monitoring, and other application. Based on end user, the market is segmented into hospitals, ambulatory surgery centers, home care settings, and others. On the basis of geography, the capnography equipment market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Factors such as the rising prevalence of respiratory disorders and clinical benefits of capnography equipment over pulse oximetry.
Stringent and ambiguous approval process of capnography equipment is expected to restrict the market growth during the forecast period
The capnography equipment market majorly consists of the players such as Medtronic, Koninklijke Philips N.V., General Electric Company, Dragerwerk AG & Co. KGaA, Nihon Kohden Corporation, Hill Rom Holding Inc. (Baxter), Masimo, SCHILLER Americas Inc., ICU MEDICAL Inc., and BD.
The global capnography equipment market based on product type, is segmented into capnometer and capnography accessories & disposables. In 2021, the capnography accessories & disposables segment held the largest share of the market, by product type. However, the capnometer segment is expected to witness growth in its demand at a fastest CAGR of 7.2% during 2022 to 2028.
The global capnography equipment market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2021, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR of 7.4% during the forecast period
The prevalence of respiratory disorders is driving the growth of capnography equipment demand. In capnography, carbon dioxide (CO2) absorbs infrared radiation, and the procedure involves the passage of infrared radiation over a gas sample collected from exhalation. In many cases, oxygen levels in the blood can remain normal for several minutes after a patient stops breathing. The capnography detects the CO2 present in the body and the detection is more accurate. The equipment can read every phase of the respiratory cycle, thereby providing more in-depth readings. The ability of capnography machines to provide robust data sets makes it easier for healthcare providers to diagnose the root causes of respiratory problems. The capnograph wavelength displays the entire breathing cycle, making it easier to track exact symptoms. Capnography is used to understand how a patient is responding to treatment as they can display the ongoing data in real time. The continuous measurement of human respiratory CO2 by using a capnograph provides valuable information about cardiopulmonary resuscitation, endotracheal tube placement, pulmonary embolism, and procedural sedation. The equipment is also used to obtain information about the effect of air pollution on cardiopulmonary characteristics and the effectiveness of a treatment for a patient with respiratory distress. The changes in the shape of the capnogram are used to diagnose respiratory disease conditions, and changes in end-tidal CO2 (EtCO2) i.e., the maximum CO2 concentration at the end of each tidal breath can be used to assess disease severity and response to treatment.